Zymvol Biomodeling

Zymvol Biomodeling

Private
BarcelonaHealthcare & Life Scienceshttps://zymvol.com/

Last Round

Seed

Feb 20, 2025

Total Funding Raised

$6.81M

Company Overview

Zymvol Biomodeling is a biotechnology company that provides computer-aided enzyme discovery and engineering services.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, ML Platforms, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

enzyme engineeringenzyme discoveryin silico designbiocatalysisprotein engineeringenzyme optimizationcomputational biologysynthetic biologysynbioAI protein designmolecular modelingcustom enzymesdrug discoverywet lab servicesclean manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zymvol Biomodeling Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Zymvol Biomodeling Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 20, 2025
DebtJan 1, 2024
SeedFeb 21, 2023
GrantOct 1, 2019

Key People

Founding team and executive leadership

Maria Fátima Lucas

Founder & Chief Executive Officer

Founding Team

Brian Jimenez

Chief Technology Officer

Executive Team

Marina Cañellas Fontanilles

Chief Operating Officer

Executive Team

Zymvol Biomodeling Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors grew 64% MoM, reaching 6.7K.

  • Feb 20, 2025

    $3.24M round led by Faber Ventures

Zymvol Biomodeling Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Zymvol Biomodeling Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Zymvol Biomodeling's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona
Employee Range32
Year Founded2017
Last FundingFeb 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.